Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Feb;18(1):69-73.
doi: 10.1007/s13365-011-0068-8. Epub 2011 Dec 30.

Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy

B Shiramizu  1 , J Ananworanich, T Chalermchai, U Siangphoe, D Troelstrup, C Shikuma, V De Grutolla, P Sithinamsuwan, P Praihirunkit, S Rattanamanee, V Valcour; SEARCH 001.1 Study Group
Collaborators, Affiliations

Failure to clear intra-monocyte HIV infection linked to persistent neuropsychological testing impairment after first-line combined antiretroviral therapy

B Shiramizu et al. J Neurovirol. 2012 Feb.

Abstract

HIV-associated neurocognitive disorders (HAND) persist despite plasma HIV RNA suppression with antiretrovirals (ARV). Sequestered reservoirs in the central nervous system and circulating monocytes are theorized to contribute to persistent brain injury. We previously demonstrated that elevated intracellular HIV DNA from circulating cells was associated with HAND in ARV-treated and ARV-naive subjects. We now report that failure to suppress intra-monocyte HIV DNA 3.5 years after initiating ARV is linked to persistent HAND and subjects with dementia are least likely to suppress intra-monocyte HIV DNA at 3.5 years. These findings suggest that antiviral strategies may need to target intra-monocyte HIV DNA.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
HIV DNA (log10 median with inter-quartile range) in peripheral mononuclear cells (PBMC, top; monocytes, middle; and monocyte-depleted PBMC, bottom) comparing dementia cases (black circle) to non-dementia cases (white circle). Some CART-naïve individuals with dementia at baseline were unable to suppress monocyte HIV DNA after 3.5 years on CART resulting in a higher median HIV DNA copies in the dementia group
See this image and copyright information in PMC

References

    1. Anekthananon T, Ratanasuwan W, Techasathit W, Sonjai A, Suwanagool S. Safety and efficacy of a simplified fixed-dose combination of stavudine, lamivudine and nevirapine (GPO-VIR) for the treatment of advanced HIV-infected patients: a 24-week study. J Med Assos Thail Suppl. 2004;87:760–767. - PubMed
    1. Burdo TH, Soulas C, Orzechowski K, Button J, Krishnan A, Sugimoto C, Alvarez X, Kuroda MJ, Williams KC. Increased monocyte turnover from bone marrow correlates with severity of SIVencephalitis and CD163 levels in plasma. PLoS Pathog. 2010;6:e1000842. - PMC - PubMed
    1. Clifford DB. HIV-associated neurocognitive disease continues in the antiretroviral era. Top HIV Med. 2008;16:94–98. - PubMed
    1. Denning DW. The neurological features of acute HIV infection. Biomed Pharmacother. 1988;42:11–14. - PubMed
    1. Ellery PJ, Tippett E, Chiu YL, Paukovics G, Cameron PU, Solomon A, Lewin SR, Gorry PR, Jaworowski A, Greene WC, Sonza S, Crowe SM. The CD16+ monocyte subset is more permissive to infection and preferentially harbors HIV-1 in vivo. J Immunol. 2007;178:6581–6589. - PubMed

Publication types